Guardant Health (GH) Receivables - Other (2019 - 2026)

Guardant Health has disclosed Receivables - Other across 8 years of filings, most recently posting $6.2 million for Q1 2026.

• Receivables - Other for Q1 2026 came in at $6.2 million, up 47.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.2 million (up 47.62% YoY), and the FY2025 annual result was $5.2 million, up 52.94% from the prior year.
• Receivables - Other came in at $6.2 million for Q1 2026 at Guardant Health, up from $5.2 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $6.2 million in Q1 2026 to a low of $3.1 million in Q1 2022.
• The 5-year median for Receivables - Other is $4.9 million (2022), against an average of $4.7 million.
• Across the five-year window, Receivables - Other plunged 83.5% in 2022 and surged 52.94% in 2025, its largest moves.
• Guardant Health's Receivables - Other stood at $5.4 million in 2022, then dropped by 9.26% to $4.9 million in 2023, then tumbled by 30.61% to $3.4 million in 2024, then jumped by 52.94% to $5.2 million in 2025, then advanced by 19.23% to $6.2 million in 2026.
• The last three Receivables - Other figures came in at $6.2 million (Q1 2026), $5.2 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.